fulvestrant has been researched along with liquiritigenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JZ; Khan, MZI; Nazli, A; Uzair, M | 1 |
| Bae, GD; Baek, DJ; Jun, HS; Oh, YS; Park, EY | 1 |
1 review(s) available for fulvestrant and liquiritigenin
| Article | Year |
|---|---|
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen | 2022 |
1 other study(ies) available for fulvestrant and liquiritigenin
| Article | Year |
|---|---|
Liquiritigenin prevents palmitate-induced beta-cell apoptosis via estrogen receptor-mediated AKT activation.
Topics: Animals; Apoptosis; Caspase 3; Cell Line; Cell Survival; eIF-2 Kinase; Endoplasmic Reticulum Stress; Estradiol; Flavanones; Fulvestrant; Insulin-Secreting Cells; Palmitates; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Rats; Receptors, Estrogen; Transcription Factor CHOP | 2018 |